Palmitoylethanolamide (Compound)
Synonyms:Palmitoylethanolamide, Palmidrol, 544-31-0, N-(2-Hydroxyethyl)hexadecanamide, Impulsin, Palmitoyl ethanolamide, Palmitamide MEA, N-palmitoylethanolamine, N-(2-Hydroxyethyl)palmitamide, Loramine P 256, Hydroxyethylpalmitamide, Palmitic acid monoethanolamide, Palmitoyl-EA, palmitylethanolamide, Palmidrolum, HEXADECANAMIDE, N-(2-HYDROXYETHYL)-, Palmidrol [INN], Monoethanolamine palmitic acid amide, Levagen, Anandamide (16:0), N-palmitoyl ethanolamine, palmitic monoethanolamide, Palmdrol prodes, N-hexadecanoylethanolamine, Palmitinsaeure-beta-hydroxyethylamid, NSC 23320, hexadecanoyl ethanolamide, NSC-23320, N-hexadecanoyl-ethanolamine, N(2-hydroxyethyl)palmitide, AM 3112, 6R8T1UDM3V, N(2-hydroxyethyl) palmitide, N-(2-hydroxyethyl)-palmitide, DTXSID4042254, CHEBI:71464, FSD-201, Palmidrol (INN), NCGC00015793-03, AM 3112;Loramine P 256;Mackpeart DR 14V, DTXCID2022254, MimyX, Palmidrolum [INN-Latin], CAS-544-31-0, SR-01000076055, EINECS 208-867-9, UNII-6R8T1UDM3V, N-(2-hydroxyethyl) hexadecanamide, Hexadecanamide,N-(2-hydroxyethyl)-, Mackpeart DR 14V, MFCD00020562, Anandamide C16:0, 2-Palmitoylaminoethanol, Palmdrol prodes (TN), Tocris-0879, n-palmitoyl ethanolamide, N-hexadecyl-ethanolamine, PALMIDROL [MI], Lopac-P-0359, PALMIDROL [MART.], Palmitoylethanolamide-[d4], Palmityoletanolamide (PEA), 2-PALMITAMIDOETHANOL, PALMIDROL [WHO-DD], CBiol_002043, Lopac0_000905, BSPBio_001454, KBioGR_000174, KBioSS_000174, MLS002153421, SCHEMBL120518, PALMITAMIDE MEA [INCI], BML2-B10, CHEMBL417675, GTPL3622, am-3112, Palmidrol|N-palmitoylethanolamine, SCHEMBL19511663, BDBM29083, KBio2_000174, KBio2_002742, KBio2_005310, KBio3_000347, KBio3_000348, Bio1_000329, Bio1_000818, Bio1_001307, Bio2_000174, Bio2_000654, HMS1361I16, HMS1791I16, HMS1989I16, HMS2234L19, HMS3264C10, HMS3266N08, HMS3374K03, HMS3402I16, HMS3411B14, HMS3649L03, HMS3675B14, Pharmakon1600-01506156, BCP29005, CS-D1253, NAE 16:0, NSC23320, Tox21_110222, ANA(16:0), LMFA08040013, NAE(16:0), NSC760371, s4708, STL454872, AKOS002676363, Tox21_110222_1, CCG-204987, DB14043, LP00905, NSC-760371, SDCCGSBI-0050880.P002, IDI1_033924, s10398, SCI-110 component palmitoylethanolamide, NCGC00015793-01, NCGC00015793-02, NCGC00015793-04, NCGC00015793-05, NCGC00015793-06, NCGC00015793-07, NCGC00015793-08, NCGC00015793-09, NCGC00015793-10, NCGC00015793-12, NCGC00024840-01, NCGC00024840-02, NCGC00024840-05, NCGC00024840-06, NCGC00024840-07, NCGC00024840-08, NCGC00024840-09, AS-14094, HY-20685, PALMITOYLETHANOLAMIDE [NFLIS-DRUG], SMR000058371, Hexadecanoic acid (2-hydroxy-ethyl)-amide, EU-0100905, FT-0778178, P2670, D08328, EN300-311967, P 0359, AB00918319_06, A904411, Q2159860, SR-01000076055-1, SR-01000076055-3, SR-01000076055-7, BRD-K68095457-001-04-4, Z2242151306
Id:4671
Description:nan
Analyze
CFDE DD-Knowledge Graph
The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Palmitoylethanolamide's neighborhood in the knowledge graph.
GDLPA Landing Pages Links
The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Palmitoylethanolamide.
Playbook Workflow Builder
The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Palmitoylethanolamide.
Results found
Linked to
| Label | Description |
|
|---|---|---|---|
 | A Substance | ||
 | Metadatata for palmidrol | ||
| DrugPage Collection: (DrugCentralID:02045; PubChem_CID:4671, FILE=drugcentral_drug_02045.json) |
Metadatata for palmidrol
DrugPage Collection: (DrugCentralID:02045; PubChem_CID:4671, FILE=drugcentral_drug_02045.json)
DISPLAY PER PAGE
10
@CFDE Workbench 2025
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.
@CFDE Workbench 2025